HHS To Invest $650M To Increase Rapid Molecular Point-Of-Care Diagnostic Tests For SARS-CoV-2

November 12, 2021

GenomeWeb (11/10) reported the Department of Health and Human Services “will invest $650 million from the American Rescue Plan to increase rapid molecular point-of-care diagnostic tests for SARS-CoV-2, the White House COVID-19 Response Team announced on W...